Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guided Treatment for Refractory Mycoplasma Pneumoniae Pneumonia
NCT07064278Completed
- Sponsor
- Hebei Children's Hospital
- Start
- Dec 2022
- Primary completion
- May 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of doxycycline and prednisone in Mycoplasma pneumonia (2 arms), sponsored by Hebei Children's Hospital. Primary endpoints: Time to fever resolution at 21 days, Time to cough resolution at 21 days and 4 more. Started Dec 2022; status: completed.
02
Drugs
doxycyclineprednisone
03
Conditions
Mycoplasma pneumonia
Beyond the preview
Go deeper on NCT07064278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07064278.